elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47713714-F2BF7EC3-2190-471F-AE48-881EEC5DF168
Q47713714-F2BF7EC3-2190-471F-AE48-881EEC5DF168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47713714-F2BF7EC3-2190-471F-AE48-881EEC5DF168
Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.
P2860
Q47713714-F2BF7EC3-2190-471F-AE48-881EEC5DF168
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47713714-F2BF7EC3-2190-471F-AE48-881EEC5DF168
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6ce826c9ea6dfd326544e3888958bcb236b8d8ad
P2860
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.